| | |||||
| lung cancer | |||||
| 新闻 | |||||
| Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic ... PURPOSEPatients receiving systemic therapy (ST) for non–small cell lung cancer (NSCLC) experience toxicities that negatively affect patient ...
| |||||
| FDA Drug Approval Decisions Expected in October 2025 - Endocrinology Advisor Lurbinectedin Plus Atezolizumab for Extensive-Stage Small-Cell Lung Cancer · Tezepelumab for Chronic Rhinosinusitis With Nasal Polyps · SYD-101 for ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment